Medtronic's smallest CoreValve heart device wins EU approval

09/27/2012 | (Boston)

European regulators have granted Medtronic CE mark approval to market CoreValve Evolut, a 23-millimeter transcatheter aortic valve. The implantable device, which is the smallest from the firm's CoreValve line, offers a minimally invasive treatment alternative to heart disease patients who are not fit for open-heart surgery.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health